Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia

Alzheimer disease (AD) is the most common neurodegenerative disease and typically affects patients older than age 65. Around this age, the number of neurons begins to gradually decrease in healthy brains, but brains of patients with AD show a marked increase in neuron death, often resulting in a sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Decourt, Boris, Noorda, Keith, Noorda, Kevin, Shi, Jiong, Sabbagh, Marwan N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632331/
https://www.ncbi.nlm.nih.gov/pubmed/36339394
http://dx.doi.org/10.2147/JEP.S265626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632331/
https://www.ncbi.nlm.nih.gov/pubmed/36339394
http://dx.doi.org/10.2147/JEP.S265626

Ejemplares similares